Quantification of the rate of change in lipoprotein-associated phospholipase A(2) over the course of time, used as an indicator of risk of cardiovascular events, and a target for certain cardiovascular drugs. The trait is Experimental Factor Ontology term EFO_0008432 (lipoprotein-associated phospholipase A(2) change measurement).